Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders

Acta Neuropathologica

Volumn 122, Issue 1, 2011, Pages 61-74

  Mundiñano, Iñaki Carril ^a   Caballero, Maria Cristina ^b   Ordóñez, Cristina ^a   Hernandez, Maria ^a   DiCaudo, Carla ^a   Marcilla, Irene ^a   Erro, Maria Elena ^b   Tuñon, Maria Teresa ^b   Luquin, Maria Rosario ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b Universidad Pública de Navarra   (Spain)

Author keywords

Alpha synuclein; Alzheimer's disease; Dopaminergic cells; Frontotemporal dementia; Olfactory bulb; Parkinson's disease; Tau; Amyloid

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE ACTIVITY; DOPAMINERGIC NERVE CELL; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; NEUROTRANSMISSION; OLFACTORY BULB; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; SMELLING DISORDER;

EID: 79959588593     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-011-0830-2     Document Type: Article

References (98)

1. I Alafuzoff T Arzberger S Al-Sarraj, et al. 2008 Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium Brain Pathol 18 484 496 18371174
2. I Alafuzoff L Parkkinen S Al-Sarraj, et al. 2008 Assessment of alpha-synuclein pathology: a study of the BrainNet Europe Consortium J Neuropathol Exp Neurol 67 125 143 18219257 10.1097/nen.0b013e3181633526
3. I Alafuzoff DR Thal T Arzberger, et al. 2009 Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium Acta Neuropathol 117 309 320 19184666 10.1007/s00401-009-0485-4 1:CAS:528: DC%2BD1MXitFSqtrg%3D
4. American-Psychiatric-Association (ed) (1987) Diagnostic and statistical manual of mental disorders. Third, revised edn. Washington, DC
5. SE Arnold EB Lee PJ Moberg, et al. 2010 Olfactory epithelium amyloid-beta and paired helical filament-tau pathology in Alzheimer disease Ann Neurol 67 462 469 20437581 10.1002/ana.21910 1:CAS:528:DC%2BC3cXntFCru7k%3D
6. J Attems KA Jellinger 2006 Olfactory tau pathology in Alzheimer disease and mild cognitive impairment Clin Neuropathol 25 265 271 17140156 1:STN:280:DC%2BD28jgt1ejtQ%3D%3D (Pubitemid 44807389)
7. TG Beach CL White RL Hamilton, et al. 2008 Evaluation of alpha-synuclein immunohistochemical methods used by invited experts Acta Neuropathol 116 277 288 18626651 10.1007/s00401-008-0409-8 1:CAS:528:DC%2BD1cXpsVGjsr4%3D
8. TG Beach CL White 3rd CL Hladik, et al. 2009 Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders Acta Neuropathol 117 169 174 18982334 10.1007/s00401-008-0450-7 1:CAS:528:DC%2BD1MXhtVCltLg%3D
9. S Belzunegui WS Sebastián P Garrido-Gil, et al. 2007 The number of dopaminergic cells is increased in the olfactory bulb of monkeys chronically exposed to MPTP Synapse 61 1006 1012 17853434 10.1002/syn.20451 1:CAS:528:DC%2BD2sXht1Knt7vP (Pubitemid 350271781)
10. DA Berkowicz PQ Trombley 2000 Dopaminergic modulation at the olfactory nerve synapse Brain Res 855 90 99 10650134 10.1016/S0006-8993(99)02342-2 1:CAS:528:DC%2BD3cXmtVOjsA%3D%3D (Pubitemid 30067698)
11. KP Bhatnagar RC Kennedy G Baron RA Greenberg 1987 Number of mitral cells and the bulb volume in the aging human olfactory bulb: a quantitative morphological study Anat Rec 218 73 87 3605663 10.1002/ar.1092180112 1:STN:280:DyaL2s3mvVGktQ%3D%3D (Pubitemid 17078697)
12. NI Bohnen S Gedela P Herath GM Constantine RY Moore 2008 Selective hyposmia in Parkinson disease: association with hippocampal dopamine activity Neurosci Lett 447 12 16 18838108 10.1016/j.neulet.2008.09.070 1:CAS:528:DC%2BD1cXht12lsbfF
13. NI Bohnen ML Muller V Kotagal, et al. 2010 Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease Brain 133 1747 1754 20413575 10.1093/brain/awq079
14. H Braak E Braak 1991 Neuropathological staging of Alzheimer-related changes Acta Neuropathol 82 239 259 1759558 10.1007/BF00308809 1:STN:280:DyaK387gtFOiug%3D%3D
15. H Braak KD Tredici U Rüb RAI de Vos ENH Jansen Steur E Braak 2003 Staging of brain pathology related to sporadic Parkinson's disease Neurobiol Aging 24 197 211 12498954 10.1016/S0197-4580(02)00065-9 (Pubitemid 36007810)
16. H Braak I Alafuzoff T Arzberger H Kretzschmar K Del Tredici 2006 Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry Acta Neuropathol 112 389 404 16906426 10.1007/s00401-006-0127-z (Pubitemid 44469160)
17. NJ Cairns EH Bigio IR Mackenzie, et al. 2007 Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration Acta Neuropathol 114 5 22 17579875 10.1007/s00401-007-0237-2 (Pubitemid 47029055)
18. Cavalieri B (1966) Geometria degli indivisibile. Unione Tipografico-Editrice. Torino
19. LK Clinton M Blurton-Jones K Myczek JQ Trojanowski FM LaFerla 2010 Synergistic interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline J Neurosci 30 7281 7289 20505094 10.1523/JNEUROSCI.0490-10.2010 1:CAS:528:DC%2BC3cXovVOisLw%3D
20. P Cras MA Smith PL Richey SL Siedlak P Mulvihill G Perry 1995 Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein cross-linking in Alzheimer disease Acta Neuropathol 89 291 295 7610759 10.1007/BF00309621 1:STN:280:DyaK2MzjsFWgtg%3D%3D
21. S Christen-Zaech R Kraftsik O Pillevuit, et al. 2003 Early olfactory involvement in Alzheimer's disease Can J Neurol Sci 30 20 25 12619779 1:STN:280:DC%2BD3s7gs12jtw%3D%3D (Pubitemid 36383210)
22. J Djordjevic M Jones-Gotman K De Sousa H Chertkow 2008 Olfaction in patients with mild cognitive impairment and Alzheimer's disease Neurobiol Aging 29 693 706 17207898 10.1016/j.neurobiolaging.2006.11.014 (Pubitemid 351410525)
23. RL Doty PF Reyes T Gregor 1987 Presence of both odor identification and detection deficits in Alzheimer's disease Brain Res Bull 18 597 600 3607528 10.1016/0361-9230(87)90129-8 1:STN:280:DyaL2s3nt1Knuw%3D%3D (Pubitemid 17121630)
24. JE Duda 2010 Olfactory system pathology as a model of Lewy neurodegenerative disease J Neurol Sci 289 49 54 19783257 10.1016/j.jns.2009.08. 042 1:CAS:528:DC%2BC3cXntVWqug%3D%3D
25. M Ennis LA Zimmer MT Shipley 1996 Olfactory nerve stimulation activates rat mitral cells via NMDA and non-NMDA receptors in vitro Neuroreport 7 989 992 8804037 10.1097/00001756-199604100-00007 1:CAS:528:DyaK28Xkt1Kmu7s%3D
26. MM Esiri GK Wilcock 1984 The olfactory bulbs in Alzheimer's disease J Neurol Neurosurg Psychiatry 47 56 60 6693914 10.1136/jnnp.47.1.56 1:STN:280:DyaL2c7htlOmtQ%3D%3D (Pubitemid 14154239)
27. M Fusetti AB Fioretti F Silvagni, et al. 2010 Smell and preclinical Alzheimer disease: study of 29 patients with amnesic mild cognitive impairment J Otolaryngol Head Neck Surg 39 175 181 20211105
28. DC German KF Manaye CL White 3rd, et al. 1992 Disease-specific patterns of locus coeruleus cell loss Ann Neurol 32 667 676 1449247 10.1002/ana.410320510 1:STN:280:DyaK3s%2FotVaqtQ%3D%3D
29. AS Ghatpande A Gelperin 2009 Presynaptic muscarinic receptors enhance glutamate release at the mitral/tufted to granule cell dendrodendritic synapse in the rat main olfactory bulb J Neurophysiol 101 2052 2061 19225175 10.1152/jn.90734.2008 1:CAS:528:DC%2BD1MXkvVWrsrY%3D
30. T Gomez-Isla R Hollister H West, et al. 1997 Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease Ann Neurol 41 17 24 9005861 10.1002/ana.410410106 1:STN:280:DyaK2s7lvVGjsw%3D%3D (Pubitemid 27057088)
31. A Grudzien P Shaw S Weintraub E Bigio DC Mash MM Mesulam 2007 Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease Neurobiol Aging 28 327 335 16574280 10.1016/j.neurobiolaging.2006.02.007 1:CAS:528:DC%2BD2sXhtlantrg%3D (Pubitemid 46178530)
32. HJ Gundersen TF Bendtsen L Korbo, et al. 1988 Some new, simple and efficient stereological methods and their use in pathological research and diagnosis APMIS 96 379 394 3288247 10.1111/j.1699-0463.1988.tb05320.x 1:STN:280:DyaL1c3ktVOjsQ%3D%3D
33. A Haehner S Boesveldt HW Berendse, et al. 2009 Prevalence of smell loss in Parkinson's disease - a multicenter study Parkinsonism Relat Disord 15 490 494 19138875 10.1016/j.parkreldis.2008.12.005 1:STN:280:DC%2BD1MvovVChtw%3D%3D
34. C Hawkes 2003 Olfaction in neurodegenerative disorder Mov Disord 18 364 372 12671941 10.1002/mds.10379 (Pubitemid 36527276)
35. CH Hawkes BC Shephard SE Daniel 1997 Olfactory dysfunction in Parkinson's disease J Neurol Neurosurg Psychiatry 62 436 446 9153598 10.1136/jnnp.62.5.436 1:STN:280:DyaK2s3psl2ltA%3D%3D (Pubitemid 27237050)
36. S Hirano H Shinotoh H Shimada, et al. 2010 Cholinergic imaging in corticobasal syndrome, progressive supranuclear palsy and frontotemporal dementia Brain 133 2058 2068 20558417 10.1093/brain/awq120
37. PV Hoogland E Huisman 1999 Tyrosine hydroxylase immunoreactive structures in the aged human olfactory bulb and olfactory peduncle J Chem Neuroanat 17 153 10609864 10.1016/S0891-0618(99)00035-6 1:CAS:528:DyaK1MXnsVKltL0%3D
38. PV Hoogland R van den Berg E Huisman 2003 Misrouted olfactory fibres and ectopic olfactory glomeruli in normal humans and in Parkinson and Alzheimer patients Neuropathol Appl Neurobiol 29 303 311 12787327 10.1046/j.1365-2990. 2003.00459.x 1:STN:280:DC%2BD3s3mt1ygtw%3D%3D (Pubitemid 36718178)
39. AY Hsia JD Vincent PM Lledo 1999 Dopamine depresses synaptic inputs into the olfactory bulb J Neurophysiol 82 1082 1085 10444702 1:CAS:528: DyaK1MXlvVant7Y%3D (Pubitemid 29387879)
40. ED Huey KT Putnam J Grafman 2006 A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia Neurology 66 17 22 16401839 10.1212/01.wnl.0000191304.55196.4d 1:CAS:528:DC%2BD2MXhtlagsb%2FK (Pubitemid 43739585)
41. AJ Hughes SE Daniel L Kilford AJ Lees 1992 Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases J Neurol Neurosurg Psychiatry 55 181 184 1564476 10.1136/jnnp.55.3.181 1:STN:280:DyaK383is1Omsg%3D%3D
42. E Huisman HBM Uylings PV Hoogland 2004 A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease Mov Disord 19 687 692 15197709 10.1002/mds.10713 (Pubitemid 39173024)
43. E Huisman HB Uylings PV Hoogland 2008 Gender-related changes in increase of dopaminergic neurons in the olfactory bulb of Parkinson's disease patients Mov Disord 23 1407 1413 18581481 10.1002/mds.22009
44. T Hummel M Witt H Reichmann A Welge-Luessen A Haehner 2010 Immunohistochemical, volumetric, and functional neuroimaging studies in patients with idiopathic Parkinson's disease J Neurol Sci 289 119 122 19775703 10.1016/j.jns.2009.08.026 1:CAS:528:DC%2BC3cXntVWqtw%3D%3D
45. N Ibarretxe-Bilbao C Junque MJ Marti, et al. 2010 Olfactory impairment in Parkinson's disease and white matter abnormalities in central olfactory areas: a voxel-based diffusion tensor imaging study Mov Disord 25 1888 1894 20669268 10.1002/mds.23208
46. KA Jellinger 2009 Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders Acta Neuropathol 117 215 216 18985364 10.1007/s00401-008-0454-3 (author reply 217-218)
47. P Kása Z Rakonczay K Gulya 1997 The cholinergic system in Alzheimer's disease Prog Neurobiol 52 511 535 9316159 10.1016/S0301-0082(97) 00028-2 (Pubitemid 27405078)
48. CL Kovács 1999 B-Amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimer's disease Neuropathol Appl Neurobiol 25 481 491 10632898 10.1046/j.1365-2990.1999.00208.x (Pubitemid 30045422)
49. I Kovacs I Torok J Zombori P Kasa 1998 Cholinergic structures and neuropathologic alterations in the olfactory bulb of Alzheimer's disease brain samples Brain Res 789 167 170 9602111 10.1016/S0006-8993(98)00097-3 1:CAS:528:DyaK1cXhvFGrurc%3D (Pubitemid 28206858)
50. T Kovács 2004 Mechanisms of olfactory dysfunction in aging and neurodegenerative disorders Ageing Res Rev 3 215 15177056 10.1016/j.arr.2003.10. 003 (Pubitemid 38230198)
51. JJ Kril S Patel AJ Harding GM Halliday 2002 Neuron loss from the hippocampus of Alzheimer's disease exceeds extracellular neurofibrillary tangle formation Acta Neuropathol 103 370 376 11904757 10.1007/s00401-001-0477-5 (Pubitemid 36097032)
52. S Lehericy EC Hirsch P Cervera-Pierot, et al. 1993 Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease J Comp Neurol 330 15 31 8468401 10.1002/cne.903300103 1:STN:280:DyaK3s3isVKiuw%3D%3D (Pubitemid 23095311)
53. S Luzzi JS Snowden D Neary M Coccia L Provinciali MA Lambon Ralph 2007 Distinct patterns of olfactory impairment in Alzheimer's disease, semantic dementia, frontotemporal dementia, and corticobasal degeneration Neuropsychologia 45 1823 1831 17270222 10.1016/j.neuropsychologia.2006.12.008 (Pubitemid 46386110)
54. Maher BJ GL Westbrook 2008 Co-transmission of dopamine and GABA in periglomerular cells J Neurophysiol 99 1559 1564 10.1152/jn.00636.2007 (Pubitemid 351413731)
55. IG McKeith DW Dickson J Lowe, et al. 2005 Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium Neurology 65 1863 1872 16237129 10.1212/01.wnl.0000187889.17253.b1 1:STN:280: DC%2BD2Mnpt1GqsQ%3D%3D (Pubitemid 43970103)
56. G McKhann D Drachman M Folstein R Katzman D Price EM Stadlan 1984 Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 939 944 6610841 1:STN:280:DyaL2c3ks1altQ%3D%3D (Pubitemid 14076461)
57. GM McKhann MS Albert M Grossman B Miller D Dickson JQ Trojanowski 2001 Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease Arch Neurol 58 1803 1809 11708987 10.1001/archneur.58.11.1803 1:STN:280:DC%2BD3MnosFymsQ%3D%3D (Pubitemid 33044246)
58. RI Mesholam PJ Moberg RN Mahr RL Doty 1998 Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases Arch Neurol 55 84 90 9443714 10.1001/archneur.55.1.84 1:STN:280:DyaK1c7gtl2msw%3D%3D (Pubitemid 28139109)
59. Mossner R, Schmitt A, Syagailo Y, Gerlach M, Riederer P, Lesch KP (2000) The serotonin transporter in Alzheimer's and Parkinson's disease. J Neural Transm Suppl (60):345-350 (Pubitemid 32037205)
60. A Mueller ND Abolmaali AR Hakimi, et al. 2005 Olfactory bulb volumes in patients with idiopathic Parkinson's disease a pilot study J Neural Transm 112 1363 15711853 10.1007/s00702-005-0280-x 1:STN:280:DC%2BD2MrhtFWhtQ%3D%3D (Pubitemid 41355964)
61. Q Nai HW Dong A Hayar C Linster M Ennis 2009 Noradrenergic regulation of GABAergic inhibition of main olfactory bulb mitral cells varies as a function of concentration and receptor subtype J Neurophysiol 101 2472 2484 19279145 10.1152/jn.91187.2008 1:CAS:528:DC%2BD1MXmtVWqur4%3D
62. Q Nai HW Dong C Linster M Ennis 2010 Activation of alpha1 and alpha2 noradrenergic receptors exert opposing effects on excitability of main olfactory bulb granule cells Neuroscience 169 882 892 20466037 10.1016/j.neuroscience. 2010.05.010 1:CAS:528:DC%2BC3cXos1ymtbg%3D
63. TG Ohm H Braak 1987 Olfactory bulb changes in Alzheimer's disease Acta Neuropathol 73 365 369 3618129 10.1007/BF00688261 1:STN:280:DyaL2s3psFSksw%3D%3D (Pubitemid 17113539)
64. M Pardini ED Huey AL Cavanagh J Grafman 2009 Olfactory function in corticobasal syndrome and frontotemporal dementia Arch Neurol 66 92 96 19139305 10.1001/archneurol.2008.521
65. L Parkkinen L Silveira-Moriyama JL Holton AJ Lees T Revesz 2009 Can olfactory bulb biopsy be justified for the diagnosis of Parkinson's disease? Comments on "olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders" Acta Neuropathol 117 213 214 19031077 10.1007/s00401-008-0462-3 (author reply 217-218)
66. RKB Pearce CH Hawkes SE Daniel 1995 The anterior olfactory nucleus in Parkinson's disease Mov Disord 10 283 287 7651444 10.1002/mds.870100309 1:STN:280:DyaK2MznvFyktg%3D%3D
67. GC Petzold A Hagiwara VN Murthy 2009 Serotonergic modulation of odor input to the mammalian olfactory bulb Nat Neurosci 12 784 791 19430472 10.1038/nn.2335 1:CAS:528:DC%2BD1MXls1Clsr8%3D
68. MJ Porritt PE Batchelor AJ Hughes R Kalnins GA Donnan DW Howells 2000 New dopaminergic neurons in Parkinson's disease striatum Lancet 356 44 45 10892768 10.1016/S0140-6736(00)02437-5 1:CAS:528:DC%2BD3cXkvVyrtr8%3D (Pubitemid 30416998)
69. RT Pressler T Inoue BW Strowbridge 2007 Muscarinic receptor activation modulates granule cell excitability and potentiates inhibition onto mitral cells in the rat olfactory bulb J Neurosci 27 10969 10981 17928438 10.1523/JNEUROSCI.2961-07.2007 1:CAS:528:DC%2BD2sXht1Wnsb7K (Pubitemid 47574152)
70. JL Price PB Davis JC Morris DL White 1991 The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease Neurobiol Aging 12 295 312 1961359 10.1016/0197-4580(91)90006-6 1:STN:280:DyaK38%2Fnt1ygtQ%3D%3D
71. B Ridha V Anderson J Barnes, et al. 2008 Volumetric MRI and cognitive measures in Alzheimer disease J Neurol 255 567 18274807 10.1007/s00415-008-0750- 9
72. P Rombaux H Potier E Markessis T Duprez T Hummel 2010 Olfactory bulb volume and depth of olfactory sulcus in patients with idiopathic olfactory loss Eur Arch Otorhinolaryngol 267 10 1551 1556 20300763 10.1007/s00405-010-1230-2
73. KS Rommelfanger D Weinshenker 2007 Norepinephrine: the redheaded stepchild of Parkinson's disease Biochem Pharmacol 74 177 190 17416354 10.1016/j.bcp.2007.01.036 1:CAS:528:DC%2BD2sXmsFKgt7g%3D (Pubitemid 46890808)
74. GW Ross H Petrovitch RD Abbott, et al. 2008 Association of olfactory dysfunction with risk for future Parkinson's disease Ann Neurol 63 167 173 18067173 10.1002/ana.21291 (Pubitemid 351355295)
75. M Ruberg F Rieger A Villageois AM Bonnet Y Agid 1986 Acetylcholinesterase and butyrylcholinesterase in frontal cortex and cerebrospinal fluid of demented and non-demented patients with Parkinson's disease Brain Res 362 83 91 3942870 10.1016/0006-8993(86)91401-0 1:CAS:528:DyaL28Xms12ltQ%3D%3D (Pubitemid 16185426)
76. W San Sebastian J Guillen M Manrique, et al. 2007 Modification of the number and phenotype of striatal dopaminergic cells by carotid body graft Brain 130 1306 1316 17439984 10.1093/brain/awm061 1:STN:280:DC%2BD2s3mtlSisQ%3D%3D (Pubitemid 47355955)
77. DA Scott I Tabarean Y Tang A Cartier E Masliah S Roy 2010 A pathologic cascade leading to synaptic dysfunction in alpha-synuclein-induced neurodegeneration J Neurosci 30 8083 8095 20554859 10.1523/JNEUROSCI.1091-10. 2010 1:CAS:528:DC%2BC3cXot1Cqt7g%3D
78. R Sengoku Y Saito M Ikemura, et al. 2008 Incidence and extent of Lewy body-related alpha-synucleinopathy in aging human olfactory bulb J Neuropathol Exp Neurol 67 1072 1083 18957894 10.1097/NEN.0b013e31818b4126
79. M Serby P Larson D Kalkstein 1991 The nature and course of olfactory deficits in Alzheimer's disease Am J Psychiatry 148 357 360 1992839 1:STN:280:DyaK3M7islOntQ%3D%3D
80. H Shimada S Hirano H Shinotoh, et al. 2009 Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET Neurology 73 273 278 19474411 10.1212/WNL.0b013e3181ab2b58 1:CAS:528:DC%2BD1MXovVShtrw%3D
81. RL Smith H Baker K Kolstad DD Spencer CA Greer 1991 Localization of tyrosine hydroxylase and olfactory marker protein immunoreactivities in the human and macaque olfactory bulb Brain Res 548 140 148 1678294 10.1016/0006-8993(91)91115-H 1:STN:280:DyaK3MzivF2mtQ%3D%3D
82. Smutzer GS Arnold SE, Doty RL, Trojanowski JQ (2003) Olfactory system neuropathology in neurodegenerative diseases and schizophrenia. In: Doty RL (ed) Handbook of olfaction and gustation, 2nd edn. Marcel Dekker, New York
83. R Stephenson D Houghton S Sundarararjan, et al. 2010 Odor identification deficits are associated with increased risk of neuropsychiatric complications in patients with Parkinson's disease Mov Disord 25 2099 2104 20669288 10.1002/mds.23234
84. BR Talamo WH Feng M Perez-Cruet, et al. 1991 Pathologic changes in olfactory neurons in Alzheimer's disease Ann NY Acad Sci 640 1 7 1776726 1:STN:280:DyaK387jtlyltA%3D%3D
85. D Tande G Hoglinger T Debeir N Freundlieb EC Hirsch C Francois 2006 New striatal dopamine neurons in MPTP-treated macaques result from a phenotypic shift and not neurogenesis Brain 129 1194 1200 16481374 10.1093/brain/awl041
86. PA Thomann V Dos Santos U Seidl P Toro M Essig J Schröder 2009 MRI-derived atrophy of the olfactory bulb and tract in mild cognitive impairment and Alzheimer's disease J Alzheimer's Dis 17 213 221
87. PA Thomann V Dos Santos P Toro P Schönknecht M Essig J Schröder 2009 Reduced olfactory bulb and tract volume in early Alzheimer's disease - a MRI study Neurobiol Aging 30 838 841 17875348 10.1016/j.neurobiolaging.2007.08. 001
88. Y Tsuboi ZK Wszolek NR Graff-Radford N Cookson DW Dickson 2003 Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4 Neuropathol Appl Neurobiol 29 503 510 14507342 10.1046/j.1365-2990.2003.00453.x 1:CAS:528:DC%2BD3sXovFentbY%3D (Pubitemid 37222724)
89. I Ubeda-Banon D Saiz-Sanchez C de la Rosa-Prieto L Argandona-Palacios S Garcia-Munozguren A Martinez-Marcos 2010 Alpha-synucleinopathy in the human olfactory system in Parkinson's disease: involvement of calcium-binding protein- and substance P-positive cells Acta Neuropathol 119 723 735 20383714 10.1007/s00401-010-0687-9 1:CAS:528:DC%2BC3cXlslWgtLw%3D
90. JP Vonsattel RH Myers TJ Stevens RJ Ferrante ED Bird EP Richardson Jr 1985 Neuropathological classification of Huntington's disease J Neuropathol Exp Neurol 44 559 577 2932539 10.1097/00005072-198511000-00003 1:STN:280: DyaL28%2Fjs1egsg%3D%3D (Pubitemid 16196286)
91. Vyhnalek M, Lodinska D, Varjassyova A, Horinek D, Laczo J, Hort J (2006) Olfactory function impairment in frontotemporal dementia is evident but less severe than in Alzheimer's disease (Abstract). Eur J Neurol 13:71
92. E Wattendorf A Welge-Lussen K Fiedler, et al. 2009 Olfactory impairment predicts brain atrophy in Parkinson's disease J Neurosci 29 15410 15413 20007465 10.1523/JNEUROSCI.1909-09.2009 1:CAS:528:DC%2BD1MXhsFOgsb%2FK
93. D Weinshenker 2008 Functional consequences of locus coeruleus degeneration in Alzheimer's disease Curr Alzheimer Res 5 342 345 18537547 10.2174/156720508784533286 1:CAS:528:DC%2BD1cXmtFakt70%3D (Pubitemid 351840281)
94. RS Wilson SE Arnold JA Schneider PA Boyle AS Buchman DA Bennett 2009 Olfactory impairment in presymptomatic Alzheimer's disease Ann NY Acad Sci 1170 730 735 19686220 10.1111/j.1749-6632.2009.04013.x
95. M Witt K Bormann V Gudziol, et al. 2009 Biopsies of olfactory epithelium in patients with Parkinson's disease Mov Disord 24 906 914 19205070 10.1002/mds.22464
96. Z Yan J Feng 2004 Alzheimer's disease: interactions between cholinergic functions and beta-amyloid Curr Alzheimer Res 1 241 248 15975053 10.2174/1567205043331992 1:CAS:528:DC%2BD2cXosVymurs%3D
97. Y Yang HP Schmitt 2001 Frontotemporal dementia: evidence for impairment of ascending serotoninergic but not noradrenergic innervation. Immunocytochemical and quantitative study using a graph method Acta Neuropathol 101 256 270 11307626 1:STN:280:DC%2BD3MvotlGkuw%3D%3D (Pubitemid 32219760)
98. C Zarow SA Lyness JA Mortimer HC Chui 2003 Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases Arch Neurol 60 337 341 12633144 10.1001/archneur.60.3.337 (Pubitemid 36314358)